MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, LGNYZ made $115,461K in revenue. $117,273K in net income. Net profit margin of 101.57%.

Income Overview

Revenue
$115,461K
Net Income
$117,273K
Net Profit Margin
101.57%
EPS
$5.68
Unit: Thousand (K) dollars
Revenue Breakdown
    • Contract Revenue And Other Incom...
    • Intangible Royalty Assets
    • Material Sales Captisol
    • Financial Royalty Assets
Revenue Breakdown
    • Income From Divestiture Transact...
    • Kyprolis
    • Material Sales Captisol
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-09-30
Total revenues and other income
115,461
Cost of captisol
3,801
Amortization of intangibles
8,097
Research and development
21,019
General and administrative
28,446
Financial royalty assets impairment
0
Fair value adjustments to partner program derivatives
833
Total operating costs and expenses
60,530
Operating income (loss)
54,931
Gain (loss) from short-term investments
7,798
Gain (loss) from change in fair value of equity-method investments and other investments
75,887
Interest income
3,874
Interest expense
910
Other non-operating expense, net
-443
Total non-operating income (expenses), net
86,206
Income (loss) before income taxes
141,137
Income tax expense
23,864
Net income (loss)
117,273
Basic net income (loss) per share (in usd per share)
5.99
Diluted net income (loss) per share (in usd per share)
5.68
Shares used in basic per share calculation (in shares)
19,578,000
Shares used in diluted per share calculation (in shares)
20,629,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Financial Royalty Assets$6,425K Intangible Royalty Assets$40,161K Contract Revenue AndOther Income$58,203K Material Sales Captisol$10,672K Royalty$46,586K Interest income$3,874K Gain (loss) fromchange in fair value of...$75,887K Gain (loss) fromshort-term investments$7,798K Total revenues andother income$115,461K Total non-operatingincome (expenses), net$86,206K Operating income (loss)$54,931K Other non-operatingexpense, net-$443K Interest expense$910K Total operating costsand expenses$60,530K Fair valueadjustments to partner...$833K Income (loss) beforeincome taxes$141,137K General andadministrative$28,446K Research and development$21,019K Amortization of intangibles$8,097K Cost of captisol$3,801K Net income (loss)$117,273K Income tax expense$23,864K

LIGAND PHARMACEUTICALS INC (LGNYZ)

LIGAND PHARMACEUTICALS INC (LGNYZ)